These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 36810364)
21. Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag. Chepurny OG; Bertinetti D; Diskar M; Leech CA; Afshari P; Tsalkova T; Cheng X; Schwede F; Genieser HG; Herberg FW; Holz GG Mol Endocrinol; 2013 Aug; 27(8):1267-82. PubMed ID: 23798572 [TBL] [Abstract][Full Text] [Related]
22. Intestinal CART is a regulator of GIP and GLP-1 secretion and expression. Shcherbina L; Lindqvist A; Thorén Fischer AH; Ahlqvist E; Zhang E; Falkmer SE; Renström E; Koffert J; Honka H; Wierup N Mol Cell Endocrinol; 2018 Nov; 476():8-16. PubMed ID: 29627317 [TBL] [Abstract][Full Text] [Related]
23. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells. Lee YS; Jun HS Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094 [TBL] [Abstract][Full Text] [Related]
24. The incretin system and its role in type 2 diabetes mellitus. Holst JJ; Vilsbøll T; Deacon CF Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605 [TBL] [Abstract][Full Text] [Related]
25. Glutamine-induced signaling pathways via amino acid receptors in enteroendocrine L cell lines. Nakamura T; Harada K; Kamiya T; Takizawa M; Küppers J; Nakajima K; Gütschow M; Kitaguchi T; Ohta K; Kato T; Tsuboi T J Mol Endocrinol; 2020 Apr; 64(3):133-143. PubMed ID: 31940281 [TBL] [Abstract][Full Text] [Related]
35. The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications. Madsbad S Diabetes Obes Metab; 2014 Jan; 16(1):9-21. PubMed ID: 23617798 [TBL] [Abstract][Full Text] [Related]
36. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. Yabe D; Seino Y Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006 [TBL] [Abstract][Full Text] [Related]
37. Incretins play an important role in FFA4/GPR120 regulation of glucose metabolism by GW-9508. McKillop AM; Miskelly MG; Moran BM; Flatt PR Life Sci; 2023 Apr; 318():121475. PubMed ID: 36754346 [TBL] [Abstract][Full Text] [Related]
38. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release. Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141 [TBL] [Abstract][Full Text] [Related]
39. Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells. Harada K; Kitaguchi T; Kamiya T; Aung KH; Nakamura K; Ohta K; Tsuboi T J Biol Chem; 2017 Jun; 292(26):10855-10864. PubMed ID: 28533434 [TBL] [Abstract][Full Text] [Related]
40. Incretin hormones: Their role in health and disease. Nauck MA; Meier JJ Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():5-21. PubMed ID: 29364588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]